Olorofim Aspergillus Infection Study

Clinical trial NCT05101187 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05101187
Sponsor: F2G Biotech GmbH
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Invasive Aspergillosis

Start date: 2022-03-31
Primary completion: 2025-11-18
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.